The Nordic Countries in International High-Technology Markets: Pharmaceuticals

Abstract

The aim of this article is to investigate the possible competitive advantages common to enterprises in more than one of the Nordic countries, and at least to some extent to explain them from specific societal or economic aspects common to the Nordic welfare states. Pharmaceutical production and export is chosen as the case study, as this is one example of an international competitive success common to most of the Nordic countries. To some extent the source of competitive advantage is the sophisticated demand for pharmaceuticals, represented by the advanced Nordic health care systems. The so-called Scandinavian welfare model may in this context be considered the source of competitive advantage generally, and the Nordic market as an advanced home market for the development of what are called welfare technologies and products.

Get full access to this article

View all access options for this article.

References

Fagerberg, J. 1986. Norden og strukturendringerne på verdensmarkedet. Statistisk Sentralbyrå 86/18 Oslo, Norway.

Hansen, K.M. & Møller, K. 1986. Dansk Medicinalindustri's internationale konkurrenceevne. Working Paper 2/1986, Institut for International Økonomi og Virksomhedsledelse, Handelshøjskolen i København .

Hansen, K.M. & Møller, K. 1987. Virksomhedernes internationale konkurrenceevne - og nationens . Ledelse og erhvervsøkonomi 3/87, Foreningen af danske civiløkonomer, København.

Lancaster, K. 1979. Variety, Equity and Efficiency London . Basil Blackwell.

Mefa 1986. Tal og data 1986. København. Medicinalfabrikantforening i Danmark.

Møller, K. 1986. En teoretisk og empirisk analyse af forholdet mellem på den ene side danske virksomheders forskning og produktudvikling, og på den anden side Dan-marks udenrigshandelsmønster, samt forslag til forbedringer af dette forhold. Handelshøjskolen i København.